This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Permax (Pergolide) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (2)
Reports by Reaction Type
Obsessive-Compulsive Disorder (1),
Hypersexuality (1),
Pathological Gambling (1),
Drug Withdrawal Syndrome (1)
Possible Permax side effects in male
Reported by a consumer/non-health professional from United States on 2012-06-07
Patient: male
Reactions: Obsessive-Compulsive Disorder, Pathological Gambling
Drug(s) suspected as cause:
Mirapex
Indication: Parkinson's Disease
Start date: 2005-01-01
End date: 2009-03-01
Permax
Start date: 1997-01-01
End date: 2005-01-01
Possible Permax side effects in 56 year old male
Reported by a physician from Japan on 2012-03-16
Patient: 56 year old male, weighing 57.0 kg (125.4 pounds)
Reactions: Hypersexuality, Drug Withdrawal Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cabergoline
Dosage: 2 mg, 1x/day
Administration route: Oral
Indication: Parkinson's Disease
End date: 2011-01-11
Selegiline Hydrochloride
Dosage: 3.75 mg, 2x/day
Administration route: Oral
Indication: Parkinson's Disease
End date: 2011-01-17
Permax
Dosage: 50 ug, 3x/day
Administration route: Oral
Indication: Parkinson's Disease
End date: 2011-01-23
Requip
Dosage: 4 mg, 3x/day
Administration route: Oral
Indication: Parkinson's Disease
Other drugs received by patient: Dops; Symmetrel; Carbidopa and Levodopa; Seroquel; Comtan; Clonazepam
|
